H06Advanced non-small cell lung cancer (Nsclc) : the prognostic role of systemic Immune-Inflammation Index (Sii)
Savini, A.; Berardi, R.; Rinaldi, S.; Santoni, M.; Newsom-Davis, T.; Tiberi, M.; Morgese, F.; Caramanti, M.; Torniai, M.; Fiordoliva, I.; Paolucci, V.; Bower, M.; Cascinu, S.
Annals of Oncology 26(Suppl 6): vi.31-vi
2015
ISSN/ISBN: 0923-7534 DOI: 10.1093/annonc/mdv343.06
Accession: 067407911
PDF emailed within 0-6 h: $19.90
Related References
Guo, D.; Zhang, J.; Jing, W.; Liu, J.; Zhu, H.; Fu, L.; Li, M.; Kong, L.; Yue, J.; Yu, J. 2018: Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer Future Oncology 14(25): 2643-2650Biswas, T.; Kang, K.H.; Gawdi, R.; Bajor, D.; Machtay, M.; Jindal, C.; Efird, J.T. 2020: Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-IIi Locally Advanced Non-Small Cell Lung Cancer (NSCLC) International Journal of Environmental Research and Public Health 17(21)
Liu, T.; Ye, F.; Li, Y.; Liu, A. 2021: Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma Annals of Palliative Medicine 10(9): 9650-9659
Aldea, M.; Benitez, J.C.; Mezquita, L. 2020: The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients Translational Lung Cancer Research 9(4): 967-970
Yucel, S.; Bilgin, B. 2021: The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 27(1): 71-77
Li, W.; Qu, Y.; Wen, F.; Yu, R.; He, X.; Jia, H.; Liu, H.; Yu, H. 2021: Prognostic nutritional index and systemic immune-inflammation index are prognostic biomarkers for non-small-cell lung cancer brain metastases Biomarkers in Medicine 15(13): 1071-1084
Mielgo Rubio, X.; Gomez Rueda, A.; Antoñanzas, M.; Falagan, S.; Núñez, J.; Sánchez Peña, A.; Gómez-Barreda, I.; Martinez Moreno, E.; Cerezo Gonzalez, S.; Cabezón Gutiérrez, L.; Sanchez Torres, J.; Jimenez Munarriz, B.; Cervera, R.; Pangua Mendez, C.; Calles Blanco, A.; Lopez Martin, A.; López Castro, R.; Sotelo Lezama, M.; Pérez Fernández, E.; Cruz, P. 2019: Applicability of lung immune prognostic index (LIPI) to predict efficacy of first-line pembrolizumab in advanced non-small cell lung cancer (NSCLC) Annals of Oncology 30: V619-V620
Alifano, M. 2020: Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer Annals of Translational Medicine 8(11): 667
Tanaka, S.; Uchino, J.; Yokoi, T.; Kijima, T.; Goto, Y.; Suga, Y.; Katayama, Y.; Nakamura, R.; Morimoto, K.; Nakao, A.; Hibino, M.; Tani, N.; Takeda, T.; Yamaguchi, H.; Tachibana, Y.; Takumi, C.; Hiraoka, N.; Takeshita, M.; Onoi, K.; Chihara, Y.; Taniguchi, R.; Yamada, T.; Matsui, Y.; Hiranuma, O.; Morimoto, Y.; Iwasaku, M.; Tokuda, S.; Kaneko, Y.; Yamada, T.; Takayama, K. 2022: Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer Diagnostics 12(2)
Li, X.; Hu, P.; Liu, J.; Zhang, J.; Liu, Q. 2020: Systemic immune-inflammation index predicted overall survival and radiosensitivity in advanced non-small-cell lung cancer Future Oncology 16(5): 103-115
Zhou, Y.; Dai, M.; Zhang, Z. 2022: Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients with Small Cell Lung Cancer: a Meta-Analysis Frontiers in Oncology 12: 814727
Wang, Y.; Li, Y.; Chen, P.; Xu, W.; Wu, Y.; Che, G. 2019: Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis Annals of Translational Medicine 7(18): 433
Berardi, R.; Santoni, M.; Rinaldi, S.; Bower, M.; Tiberi, M.; Morgese, F.; Caramanti, M.; Savini, A.; Ferrini, C.; Torniai, M.; Fiordoliva, I.; Newsom-Davis, T. 2019: Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer Annals of Translational Medicine 7(20): 572
Bauckneht, M.; Genova, C.; Rossi, G.; Rijavec, E.; Dal Bello, M.G.; Ferrarazzo, G.; Tagliamento, M.; Donegani, M.I.; Biello, F.; Chiola, S.; Zullo, L.; Raffa, S.; Lanfranchi, F.; Cittadini, G.; Marini, C.; Lopci, E.; Sambuceti, G.; Grossi, F.; Morbelli, S. 2021: The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab Cancers 13(13)
Fu, F.; Deng, C.; Wen, Z.; Gao, Z.; Zhao, Y.; Han, H.; Zheng, S.; Wang, S.; Li, Y.; Hu, H.; Zhang, Y.; Chen, H. 2021: Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer Translational Lung Cancer Research 10(7): 3144-3154
Li, A.; Mu, X.; He, K.; Wang, P.; Wang, D.; Liu, C.; Yu, J. 2020: Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases Future Oncology 16(30): 2433-2444
Mielgo Rubio, X.; Sereno Moyano, M.; Chara, L.E.; López-Castro, R.; Rubio-Martínez, J.; Velastegui, A.; Olier-Garate, C.; Falagán, S.; Gómez-Barreda, I.; Riquelme, A.; Silva-Ruiz, J.; Moreno-Rubio, J.; López, C.; Bueno, C.; Cardeña, A.; Pérez-Fernández, E.; Martí-Castelló, M.P.; Sotelo-Lezama, M.J. 2018: Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients Annals of Oncology: Official Journal of the European Society for Medical Oncology 29 Suppl. 8: Viii 510
Biswas, T.; Kang, K.; Bajor, D.; Machtay, M.; Efird, J. 2020: Using the Systemic Inflammation Index (SII) as a Mid-Treatment Marker for Overall Survival among Patients Undergoing Chemo-Radiation Therapy for Stage-IIi Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Secondary Analysis of PROCLAIM Trial International Journal of Radiation Oncology*Biology*Physics 108(3): S103-S104
Jafri, S.H.; Shi, R.; Mills, G. 2013: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review Bmc Cancer 13: 158
Wang, C.; Jin, S.; Xu, S.; Cao, S. 2020: High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy Lung 198(2): 405-414